Published in Neurobiol Dis on May 14, 2016
Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry (2017) 0.76
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
Genetics of mouse behavior: interactions with laboratory environment. Science (1999) 10.74
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) (2002) 9.90
A mouse for all reasons. Cell (2007) 9.01
A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
The knockout mouse project. Nat Genet (2004) 7.80
Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci (2003) 7.44
Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci (2001) 6.86
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
Capture of authentic embryonic stem cells from rat blastocysts. Cell (2008) 6.60
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci (2005) 5.93
The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci (2002) 5.93
An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell (2011) 5.75
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci (1996) 5.53
Germline competent embryonic stem cells derived from rat blastocysts. Cell (2008) 5.52
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science (1995) 5.19
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci (2005) 4.83
Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl (1971) 4.49
Brain dopamine and reward. Annu Rev Psychol (1989) 4.41
Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
The European dimension for the mouse genome mutagenesis program. Nat Genet (2004) 3.84
Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res (1997) 3.70
Relapse rates in addiction programs. J Clin Psychol (1971) 3.69
CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell (2014) 3.68
Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature (1994) 3.64
From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology (2002) 3.56
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron (1997) 3.19
Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature (1993) 3.09
The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell (2003) 3.09
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00
Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology (2004) 2.99
Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci (2008) 2.93
Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics (2007) 2.89
Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA (2010) 2.85
The mouse ascending: perspectives for human-disease models. Nat Cell Biol (2007) 2.74
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature (1991) 2.70
The dopamine hypothesis of reward: past and current status. Trends Neurosci (1999) 2.68
microRNAs at the synapse. Nat Rev Neurosci (2009) 2.66
Neurobiology of the incubation of drug craving. Trends Neurosci (2011) 2.65
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol (2014) 2.51
A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci (2004) 2.47
A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav (1997) 2.47
The use of behavioral test batteries: effects of training history. Physiol Behav (2001) 2.20
Neural bases for addictive properties of benzodiazepines. Nature (2010) 2.17
Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol (2008) 2.17
Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur J Neurosci (2006) 2.15
Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol (2010) 2.08
Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry (1973) 2.03
The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) (2013) 2.01
Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci Biobehav Rev (2002) 2.00
Neurotrophic factors and structural plasticity in addiction. Neuropharmacology (2008) 1.99
Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci (2002) 1.96
Ethanol drinking in rodents: is free-choice drinking related to the reinforcing effects of ethanol? Alcohol (2008) 1.95
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp Neurol (2000) 1.91
Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science (1962) 1.90
Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J (2008) 1.87
Self renewal, expansion, and transfection of rat spermatogonial stem cells in culture. Proc Natl Acad Sci U S A (2005) 1.83
MicroRNA loss enhances learning and memory in mice. J Neurosci (2010) 1.82
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol (2007) 1.72
microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci (2009) 1.71
Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav (2005) 1.70
Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet (2009) 1.59
Genetically modified mice and cognition. Curr Opin Neurobiol (1998) 1.58
Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry (2009) 1.48
Generating knockout rats by transposon mutagenesis in spermatogonial stem cells. Nat Methods (2010) 1.46
GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function. PLoS Genet (2015) 1.45
Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nat Neurosci (2015) 1.43
Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens. Biol Psychiatry (2010) 1.41
BDNF is a negative modulator of morphine action. Science (2012) 1.41
Neurobehavioral assessment in the information age. Nat Neurosci (2004) 1.41
Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science (2009) 1.40
Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol (1994) 1.40
Drug reinforcement studied by the use of place conditioning in rat. Brain Res (1982) 1.39
GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc Natl Acad Sci U S A (2008) 1.35
Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav (2004) 1.32
Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev (2009) 1.31
APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J (2011) 1.31
The "isolation syndrome" in mice. Psychopharmacologia (1973) 1.31
Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res (2010) 1.30
Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacology (2008) 1.30
Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull (1995) 1.29
RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J Neurosci (2006) 1.27
Biotechnology: Rewriting a genome. Nature (2013) 1.27
Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75